Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
- PMID: 33347498
- PMCID: PMC7751847
- DOI: 10.1371/journal.ppat.1009167
Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
Abstract
[This corrects the article DOI: 10.1371/journal.ppat.1008477.].
Erratum for
-
Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.PLoS Pathog. 2020 Apr 6;16(4):e1008477. doi: 10.1371/journal.ppat.1008477. eCollection 2020 Apr. PLoS Pathog. 2020. PMID: 32251475 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
